Dynamic Plasticity of Prostate Cancer Intermediate Cells During Androgen Receptor-Targeted Therapy

The authors identified steady-state transcriptional heterogeneity in androgen receptor and neuroendocrine biomarkers, including intermediate subpopulations that are coordinately high for prostate-specific antigen and neuron-specific enoclase promoter activity.